Antiangiogenetische Therapie beim Nierenzellkarzinom: Management der Nebenwirkungen

Author: Staehler M.   Haseke N.   Schöppler G.   Stadler T.   Heinemann G.   Stief C.  

Publisher: Springer Publishing Company

ISSN: 0340-2592

Source: Der Urologe A, Vol.45, Iss.10, 2006-10, pp. : 1333-1344

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next